- The neuroprotective compound P7C3-A20 was proposed as a therapeutic for stroke.
- P7C3-A20 reduced sensorimotor and cognitive deficits that occur after stroke.
- P7C3-A20 significantly increased neurogenesis in both neurogenic niches.
- P7C3-A20 significantly reduced both hippocampal and cortical atrophy which was strongly correlated to tissue sparing.
- P7C3-A20 treatment enhanced flux of nicotinamide adenine dinucleotide.
- Aminopropyl carbazole;
- Ischemic stroke;